Muslce Oxygenation of the Quadricep Relative to Angle and Load
Launched by UNIVERSITY OF BRITISH COLUMBIA · Oct 10, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how the amount of oxygen in your muscles changes during resistance exercises like lifting weights. Researchers want to see if this oxygen level is related to how strong your muscles are and the position of your knee while exercising. If you decide to participate, you will visit the lab three times over three weeks. During your first visit, you’ll find out how much weight you can lift in one go, and in the following sessions, you’ll do exercises with different weights using two special machines. Each session will include about 25-30 minutes of exercise, with breaks to rest in between.
To be part of this trial, you need to be able to speak and understand English and answer “No” to all questions on a physical activity questionnaire. You should not smoke or have any serious health issues, like uncontrolled heart problems or diabetes. Also, if you have any medical conditions that might affect your ability to exercise, this study may not be suitable for you. The trial is currently not recruiting participants, but it’s designed for adults aged 18 to 39 who are generally healthy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Able to understand and communicate in English
- • 2. All "No" answers on the CSEP Get Active questionnaire
- Exclusion Criteria:
- • 1. Current use of cigarettes or other nicotine devices
- • 2. Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
- • 3. Any medical condition impacting the ability to participate in maximal exercise
- • 4. Type one or type two diabetes
- • 5. Diagnosis of cancer or undergoing cancer treatment in the past 12 months
- • 6. Drug therapy with any drugs that alter skeletal muscle metabolism (i.e., Metformin, Benzodiazepines, hormone replacement therapy drugs)
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Cameron Mitchell, B.kin, MSc, PhD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported